Olga M. Santiago

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Irl B. Hirsch, Bruce W. Bode, Satish K. Garg et al. · Diabetes Care · 2005 · 199 citations

Effects of liraglutide (NN2211), a long‐acting GLP‐1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes

Mark N. Feinglos, Mohammed Saad, F X Pi-Sunyer et al. · Diabetic Medicine · 2005 · 148 citations · Full text

How Long Should Insulin Be Used Once a Vial Is Started?

Martin M. Grajower, Charles Fraser, John H. Holcombe et al. · Diabetes Care · 2003 · 55 citations · Full text

Artificial Pancreas, Metabolic Syndrome, Diabetes Epidemiology +16

Accuracy and Precision of the Novopen® 3 Insulin Delivery Device after Mechanical and Temperature Stresses

Olga M. Santiago, Naum Khutoryansky, C.M. Bilbo et al. · Endocrine Practice · 2002 · 13 citations

Novopen® 3, Temperature Stresses, Insulin Management +9